Clocortolone is a corticosteroid used to treat inflammatory and pruritic dermatoses of the scalp.
- Mechanism
- Curator reviewed
The precise mechanism of the antiinflammatory activity of topical steroids in the treatment of steroid-responsive dermatoses, in general, is uncertain. However, corticosteroids are thought to act by the induction of phospholipase A2 inhibitory proteins, collectively called lipocortins. It is postulated that these proteins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor arachidonic acid. Arachidonic acid is released from membrane phospholipids by phospholipase A2. These enzyme transcriptional changes are mediated by the drug binding first to the glucocorticoid receptor. This complex can migrate to the cell nucleus which then binds to DNA initiating genetic activation and repression of various genes.
- Primary indication
- For short-term topical treatment of the inflammatory and pruritic manifestations of moderate to severe corticosteroid-responsive dermatoses of the scalp.Curator reviewed · 1 structured indication
- Formula / weight
- C22H28ClFO4 · 410.907 g/mol (avg)
- First approval
- United States, 1977
- Code names
- SH 863
- Brand names
Resolves to
YMTMADLUXIRMGX-RFPWEZLHSA-NSMILES[H][C@@]12C[C@@H](C)[C@H](C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12CWhat you can answer from here — as of September 16, 2026
Which drugs share a target with Clocortolone, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account